Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Friday, July 10, 2026
🇪🇺 EMA

linvoseltamab News

🇪🇺 EMA ← All news

EMA linvoseltamab coverage for business development, investment, and market access teams

High impact AnalysisMay 1, 2026

EMA Conditional Marketing Authorization: Linvoseltamab for RRMM in EU

EMA · oncology · 8 min

Dr. Yuna Park
High impact AnalysisApr 22, 2026

PRAC Safety Signal Assessment: Insights on Bispecific Antibodies in Hematologic Malignancies

EMA · hematologic malignancies · 4 min

Dr. Elena Rossi
High impact AnalysisApr 21, 2026

EMA Conditional Approval Pathway: Linvoseltamab and Oncology Access in EU

EMA · oncology · 10 min

Dr. Elena Rossi

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.